Donor cell‐derived chronic myelomonocytic leukemia presenting after allogeneic hematopoietic cell transplantation for T‐cell acute lymphoblastic leukemia

Clinical Case Reports

Ryan S. Robetorye¹  Kevin C. Miller²  Zaid H. Abdel Rahman³  James M. Foran³ 

[1] Department of Laboratory Medicine and Pathology Mayo Clinic Phoenix AZ USA;Department of Medicine Massachusetts General Hospital Boston MA USA;Division of Hematology/Oncology Mayo Clinic Jacksonville FL USA;

关键词: allogeneic hematopoietic cell transplant;    chronic myelomonocytic leukemia;    CMML;    donor cell leukemia;    stem cell transplant;   

DOI  :  10.1002/ccr3.3383

来源: DOAJ

【 摘 要 】

Abstract Donor cell leukemia is a very rare cause of relapse after allogeneic hematopoietic cell transplantation (alloHCT). Herein, we describe an unprecedented case of donor cell‐derived chronic myelomonocytic leukemia (CMML) presenting seven years after a 51‐year‐old man received a matched‐related alloHCT from his 59‐year‐old brother for T‐cell acute lymphoblastic leukemia.

【 授权许可】

Unknown